15th Annual Lysosomal Storage Disease Symposium

Friday, November 21, 2025, 8:45 AM - 4:00 PM PST, Cedars-Sinai Advanced Health Science Pavilion Educational Center, Los Angeles, CA


This continuing medical education conference provides a comprehensive update on lysosomal storage disorders (LSDs) for multidisciplinary healthcare teams. LSDs are genetic conditions caused by deficiencies in lysosomal components, primarily enzymes, which lead to lysosomal dysfunction and have widespread effects on peripheral organs and the central nervous system. Participants will explore the latest advances in the identification and diagnosis of LSDs, as well as current understanding of their pathophysiology. The course will also cover updates on management strategies and treatment options, emphasizing the translation of scientific breakthroughs into clinical practice. Expert faculty will present various clinical cases for discussion, along with research updates and case reports that highlight recent developments in the field. This conference aims to enhance the ability of healthcare professionals to provide optimal care for patients with these rare but debilitating disorders, equipping attendees with up-to-date knowledge to improve early diagnosis, implement appropriate management plans, and incorporate emerging therapies into their clinical practice.

1. Apply updated knowledge of lysosomal storage disorders to improve diagnostic accuracy, develop prognoses, contribute to research, and enhance patient care
2. Identify the association between Gaucher disease and cancer
3. Describe the benefits, risks and limitations of newborn screening for lysosomal storage disorders in California
4. Analyze and integrate knowledge of Lysosomal Storage Disorders (LSDs) to collaborate effectively within interprofessional teams, facilitating improved patient care outcomes.

In-Person
In-Person: All Other Healthcare Providers - $0.00

Virtual
Virtual: All Other Healthcare Providers - $0.00

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (5.50 hours), IPCE (5.50 hours), Non-Physician AMA Attendance (5.50 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, November 21, 2025